RESTORIGIN Trademark

Trademark Overview

On Friday, January 27, 2017, a trademark application was filed for RESTORIGIN with the United States Patent and Trademark Office. The USPTO has given the RESTORIGIN trademark a serial number of 87213731. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Tuesday, November 28, 2023. This trademark is owned by Parametrics Medical, LLC. The RESTORIGIN trademark is filed in the Pharmaceutical Products category with the following description:

Human allograft tissues for homologous use in surgical and therapeutic procedures
restorigin

General Information

Serial Number87213731
Word MarkRESTORIGIN
Filing DateFriday, January 27, 2017
Status701 - SECTION 8 - ACCEPTED
Status DateTuesday, November 28, 2023
Registration Number5287865
Registration DateTuesday, September 12, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 28, 2017

Trademark Statements

Goods and ServicesHuman allograft tissues for homologous use in surgical and therapeutic procedures
Pseudo MarkREST ORIGIN

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 28, 2016
Primary Code005
First Use Anywhere DateMonday, May 1, 2017
First Use In Commerce DateMonday, May 1, 2017

Trademark Owner History

Party NameParametrics Medical, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressLeander, TX 78641
Party NameParametrics Medical, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressKalamazoo, MI 49009
Party NameParametrics Medical, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressKalamazoo, MI 49009

Trademark Events

Event DateEvent Description
Tuesday, November 28, 2023NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Tuesday, November 28, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED
Tuesday, November 28, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, August 17, 2023TEAS SECTION 8 RECEIVED
Monday, September 12, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, August 12, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 12, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 12, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 12, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, August 8, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sunday, August 6, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, July 28, 2017STATEMENT OF USE PROCESSING COMPLETE
Friday, June 30, 2017USE AMENDMENT FILED
Wednesday, July 26, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 30, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, May 23, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 28, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, February 18, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 27, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 27, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 27, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 26, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 26, 2017NON-FINAL ACTION E-MAILED
Thursday, January 26, 2017NON-FINAL ACTION WRITTEN
Monday, January 23, 2017ASSIGNED TO EXAMINER
Saturday, October 29, 2016NOTICE OF PSEUDO MARK E-MAILED
Friday, October 28, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 27, 2016NEW APPLICATION ENTERED

Related Keywords

restorigin therapeutic procedures surgical homologous allograft tissues human